Polymeric Vesicles: From Drug Carriers to Nanoreactors and Artificial Organelles
2011
One strategy in modern medicine is the development of new platforms that combine multifunctional compounds with stable, safe carriers in patient-oriented therapeutic strategies. The simultaneous detection and treatment of pathological events through interactions manipulated at the molecular level offer treatment strategies that can decrease side effects resulting from conventional therapeutic approaches. Several types of nanocarriers have been proposed for biomedical purposes, including inorganic nanoparticles, lipid aggregates, including liposomes, and synthetic polymeric systems, such as vesicles, micelles, or nanotubes.Polymeric vesicles—structures similar to lipid vesicles but created using synthetic block copolymers—represent an excellent candidate for new nanocarriers for medical applications. These structures are more stable than liposomes but retain their low immunogenicity. Significant efforts have been made to improve the size, membrane flexibility, and permeability of polymeric vesicles and to ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
88
References
468
Citations
NaN
KQI